MiMedx Group Inc (MDXG)
7.495
+0.20
(+2.81%)
USD |
NASDAQ |
May 02, 16:00
7.495
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Max Drawdown (5Y): 85.30% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 85.30% |
| March 31, 2024 | 85.30% |
| February 29, 2024 | 85.80% |
| January 31, 2024 | 86.80% |
| December 31, 2023 | 86.80% |
| November 30, 2023 | 86.80% |
| October 31, 2023 | 89.76% |
| September 30, 2023 | 93.60% |
| August 31, 2023 | 93.60% |
| July 31, 2023 | 93.60% |
| June 30, 2023 | 93.60% |
| May 31, 2023 | 93.60% |
| April 30, 2023 | 93.60% |
| March 31, 2023 | 93.60% |
| February 28, 2023 | 93.60% |
| January 31, 2023 | 93.60% |
| December 31, 2022 | 93.60% |
| November 30, 2022 | 93.60% |
| October 31, 2022 | 93.60% |
| September 30, 2022 | 93.60% |
| August 31, 2022 | 93.60% |
| July 31, 2022 | 93.60% |
| June 30, 2022 | 93.60% |
| May 31, 2022 | 93.60% |
| April 30, 2022 | 93.60% |
| Date | Value |
|---|---|
| March 31, 2022 | 93.60% |
| February 28, 2022 | 93.60% |
| January 31, 2022 | 93.60% |
| December 31, 2021 | 93.60% |
| November 30, 2021 | 93.60% |
| October 31, 2021 | 93.60% |
| September 30, 2021 | 93.60% |
| August 31, 2021 | 93.60% |
| July 31, 2021 | 93.60% |
| June 30, 2021 | 93.60% |
| May 31, 2021 | 93.60% |
| April 30, 2021 | 93.60% |
| March 31, 2021 | 93.60% |
| February 28, 2021 | 93.60% |
| January 31, 2021 | 93.60% |
| December 31, 2020 | 93.60% |
| November 30, 2020 | 93.60% |
| October 31, 2020 | 93.60% |
| September 30, 2020 | 93.60% |
| August 31, 2020 | 93.60% |
| July 31, 2020 | 93.60% |
| June 30, 2020 | 93.60% |
| May 31, 2020 | 93.60% |
| April 30, 2020 | 93.60% |
| March 31, 2020 | 93.60% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
85.30%
Minimum
Mar 2024
93.60%
Maximum
May 2019
92.79%
Average
93.60%
Median
May 2019
Max Drawdown (5Y) Benchmarks
| TELA Bio Inc | -- |
| Amylyx Pharmaceuticals Inc | -- |
| CEL-SCI Corp | 96.13% |
| AIM ImmunoTech Inc | 99.76% |
| IGC Pharma Inc | 97.77% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 2.624 |
| Beta (5Y) | 1.442 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 74.40% |
| Historical Sharpe Ratio (5Y) | 0.2513 |
| Historical Sortino (5Y) | 0.4058 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 26.81% |